These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 23702885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database.
    Farioli A, Ottone M, Morganti AG, Compagnone G, Romani F, Cammelli S, Mattioli S, Violante FS.
    Cancer Med; 2016 May; 5(5):950-9. PubMed ID: 26860323
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.
    Lönn S, Gilbert ES, Ron E, Smith SA, Stovall M, Curtis RE.
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):464-74. PubMed ID: 20142245
    [Abstract] [Full Text] [Related]

  • 6. Post-irradiation malignant mesothelioma.
    Cavazza A, Travis LB, Travis WD, Wolfe JT, Foo ML, Gillespie DJ, Weidner N, Colby TV.
    Cancer; 1996 Apr 01; 77(7):1379-85. PubMed ID: 8608519
    [Abstract] [Full Text] [Related]

  • 7. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE, Rodríguez D, Nagle RT, Mossanen M, Kibel AS, Chang SL.
    Urol Oncol; 2018 Nov 01; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.
    Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E.
    Lancet Oncol; 2011 Apr 01; 12(4):353-60. PubMed ID: 21454129
    [Abstract] [Full Text] [Related]

  • 12. Cancer incidence after localized therapy for prostate cancer.
    Moon K, Stukenborg GJ, Keim J, Theodorescu D.
    Cancer; 2006 Sep 01; 107(5):991-8. PubMed ID: 16878323
    [Abstract] [Full Text] [Related]

  • 13. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
    Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF.
    Cancer Lett; 2006 Jul 08; 238(1):42-52. PubMed ID: 16039041
    [Abstract] [Full Text] [Related]

  • 14. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
    Huo D, Hetzel JT, Roy H, Rubin DT.
    Cancer Epidemiol Biomarkers Prev; 2009 Jul 08; 18(7):1979-85. PubMed ID: 19531678
    [Abstract] [Full Text] [Related]

  • 15. Increased risk of colon cancer after external radiation therapy for prostate cancer.
    Rapiti E, Fioretta G, Verkooijen HM, Zanetti R, Schmidlin F, Shubert H, Merglen A, Miralbell R, Bouchardy C.
    Int J Cancer; 2008 Sep 01; 123(5):1141-5. PubMed ID: 18546265
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
    Chang ET, Lau EC, Mowat FS, Teta MJ.
    Cancer Causes Control; 2017 Sep 01; 28(9):971-979. PubMed ID: 28755241
    [Abstract] [Full Text] [Related]

  • 17. Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
    Guo X, Liu M, Hou H, Liu S, Zhang X, Zhang Y, Wu P, Pang C, Wang J.
    Int J Clin Oncol; 2019 Aug 01; 24(8):957-965. PubMed ID: 30903422
    [Abstract] [Full Text] [Related]

  • 18. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
    Wu Y, Li Y, Han C, Chong Y, Kang K, Liu Z, Zhang F.
    Future Oncol; 2022 Feb 01; 18(4):445-455. PubMed ID: 35018785
    [Abstract] [Full Text] [Related]

  • 19. The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer.
    Jahreiß MC, Incrocci L, Aben KKH, De Vries KC, Hoogeman M, Hooning MJ, Heemsbergen WD.
    Acta Oncol; 2024 Jun 30; 63():511-517. PubMed ID: 38946286
    [Abstract] [Full Text] [Related]

  • 20. Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality.
    Keehn A, Ludmir E, Taylor J, Rabbani F.
    World J Urol; 2017 May 30; 35(5):713-720. PubMed ID: 27629559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.